Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Mazoyer (2005)Genomic rearrangements in the BRCA1 and BRCA2 genes
Human Mutation, 25
U. Hamann, X. Liu, S. Lange, H. Ulmer, A. Benner, R. Scott (2002)Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany
Journal of Medical Genetics, 39
Yk Lim, P. Iau, Azhar Ali, S. Lee, J. Wong, T. Putti, J. Sng (2007)Identification of novel BRCA large genomic rearrangements in Singapore Asian breast and ovarian patients with cancer
Clinical Genetics, 71
P. Ghadirian, A. Robidoux, Phil Zhang, R. Royer, Mohammad Akbari, Shiyu Zhang, Eve Fafard, M. Costa, G. Martin, C. Potvin, E. Patocskai, N. Larouche, R. Younan, E. Nassif, Sylvie Giroux, S. Narod, François Rousseau, William Foulkes (2009)The contribution of founder mutations to early‐onset breast cancer in French‐Canadian women
Clinical Genetics, 76
F. Guénard, Y. Labrie, G. Ouellette, C. Beauparlant, F. Durocher (2009)Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian Families with high risk of breast cancer
Journal of Human Genetics, 54
D. Easton, A. Deffenbaugh, D. Pruss, Cynthia Frye, R. Wenstrup, K. Allen-Brady, S. Tavtigian, A. Monteiro, E. Iversen, F. Couch, D. Goldgar (2007)A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
American journal of human genetics, 81 5
M. King, J. Marks, Jessica Mandell (2003)Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
J. Simard, M. Dumont, A. Moisan, V. Gaborieau, H. Vézina, F. Durocher, J. Chiquette, M. Plante, D. Avard, P. Bessette, Claire Brousseau, M. Dorval, B. Godard, L. Houde, Y. Joly, Marie-Andrée Lajoie, G. Leblanc, Jean Lépine, B. Lespérance, H. Malouin, J. Parboosingh, R. Pichette, L. Provencher, J. Rhéaume, D. Sinnett, C. Samson, J. Simard, Martine Tranchant, Patricia Voyer, D. Easton, S. Tavtigian, B. Knoppers, R. Laframboise, P. Bridge, D. Goldgar (2006)Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer
Journal of Medical Genetics, 44
A. Manning, D. Abelovich, P. Ghadirian, Julie Lambert, D. Frappier, D. Provencher, A. Robidoux, T. Peretz, S. Narod, A. Mes-Masson, W. Foulkes, Teiling Wang, K. Morgan, T. Fujiwara, P. Tonin (2001)Haplotype Analysis of BRCA2 8765delAG Mutation Carriers in French Canadian and Yemenite Jewish Hereditary Breast Cancer Families
Human Heredity, 52
P. Tonin (2006)[The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
Bulletin du cancer, 93 9
A. Tal, Rinat Arbel-Goren, J. Stavans (2009)Cancer-associated mutations in BRC domains of BRCA2 affect homologous recombination induced by Rad51.
Journal of molecular biology, 393 5
K. Oros, P. Ghadirian, C. Maugard, C. Perret, Yosabeth Paredes, A. Mes-Masson, W. Foulkes, W. Foulkes, D. Provencher, P. Tonin, P. Tonin (2006)Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent
Clinical Genetics, 70
Anne Petrij-Bosch, T. Peelen, M. Vliet, R. Eijk, R. Olmer, M. Drüsedau, F. Hogervorst, S. Hageman, P. Arts, M. Ligtenberg, H. Meijers-Heijboer, J. Klijn, H. Vasen, C. Cornelisse, L. Veer, E. Bakker, G. Ommen, P. Devilee (1997)BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
Nature Genetics, 17
S. Arcand, C. Maugard, P. Ghadirian, A. Robidoux, C. Perret, Phil Zhang, Eve Fafard, A. Mes-Masson, W. Foulkes, D. Provencher, S. Narod, P. Tonin (2008)Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families
Breast Cancer Research and Treatment, 108
M. Tischkowitz, B. Xia, N. Sabbaghian, J. Reis-Filho, N. Hamel, Guilan Li, E. Beers, Lili Li, T. Khalil, Louise Quenneville, A. Omeroglu, A. Poll, P. Lepage, N. Wong, P. Nederlof, A. Ashworth, P. Tonin, S. Narod, D. Livingston, W. Foulkes (2007)Analysis of PALB2/FANCN-associated breast cancer families
Proceedings of the National Academy of Sciences, 104
D. Evans, F. Lalloo, A. Wallace, N. Rahman (2005)Update on the Manchester Scoring System for BRCA1 and BRCA2 testing
Journal of Medical Genetics, 42
M Tischkowitz, B Xia, N Sabbaghian (2007)Analysis of PALB2/FANCN-associated breast cancer families
Proc Natl Acad Sci U S A, 104
S. Armaou, I. Konstantopoulou, T. Anagnostopoulos, E. Razis, I. Boukovinas, N. Xenidis, G. Fountzilas, D. Yannoukakos (2007)Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
European journal of cancer, 43 2
T. Walsh, S. Casadei, Kathryn Coats, E. Swisher, S. Stray, Jake Higgins, Kevin Roach, Jessica Mandell, Ming Lee, S. Ciernikova, L. Foretova, P. Souček, M. King (2006)Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
JAMA, 295 12
Eunjung Lee, R. Mckean‐Cowdin, Huiyan Ma, Zhengjia Chen, D. Berg, B. Henderson, L. Bernstein, G. Ursin (2008)Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients
Breast Cancer Research : BCR, 10
S. Agata, M. Palma, M. Callegaro, M. Scaini, C. Menin, C. Ghiotto, O. Nicoletto, G. Zavagno, L. Chieco‐Bianchi, E. D'andrea, M. Montagna (2005)Large genomic deletions inactivate the BRCA2 gene in breast cancer families
Journal of Medical Genetics, 42
N. Puget, N. Puget, D. Stoppa-Lyonnet, O. Sinilnikova, O. Sinilnikova, S. Pagès, H. Lynch, G. Lenoir, G. Lenoir, S. Mazoyer, S. Mazoyer (1999)Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions.
Cancer research, 59 2
S. Gad, A. Aurias, N. Puget, A. Mairal, C. Schurra, M. Montagna, S. Pagès, V. Caux, S. Mazoyer, A. Bensimon, D. Stoppa-Lyonnet (2001)Color bar coding the BRCA1 gene on combed DNA: A useful strategy for detecting large gene rearrangements
A. Antoniou, D. Easton (2006)Models of genetic susceptibility to breast cancer
N Loman, O Johannsson, U Kristoffersson, H Olsson, A Borg (2001)Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer
J Natl Cancer Inst, 93
J. Schouten, C. Mcelgunn, R. Waaijer, D. Zwijnenburg, Filip Diepvens, G. Pals (2002)Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.
Nucleic acids research, 30 12
P. Tonin, A. Mes-Masson, P. Futreal, K. Morgan, Michelle Mahon, W. Foulkes, W. Foulkes, D. Cole, D. Provencher, P. Ghadirian, S. Narod (1998)Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.
American journal of human genetics, 63 5
C. Gilks, J. Prat (2009)Ovarian carcinoma pathology and genetics: recent advances.
Human pathology, 40 9
P. Pohlreich, M. Zikan, J. Stribrna, Z. Kleibl, M. Janatová, J. Kotlas, J. Židovská, J. Novotný, L. Petruželka, C. Szabo, B. Matouš (2005)High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area
Breast Cancer Research, 7
K. Oros, G. Leblanc, S. Arcand, Zhen Shen, C. Perret, A. Mes-Masson, W. Foulkes, P. Ghadirian, D. Provencher, P. Tonin (2006)Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families
BMC Medical Genetics, 7
P. Tonin, C. Perret, Julie Lambert, A. Paradis, Tania Kantemiroff, Marie‐Hélène Benoît, G. Martin, W. Foulkes, P. Ghadirian (2001)Founder BRCA1 and BRCA2 mutations in early‐onset French Canadian breast cancer cases unselected for family history
International Journal of Cancer, 95
A. Moisan, J. Fortin, M. Dumont, C. Samson, P. Bessette, J. Chiquette, R. Laframboise, Jean Lépine, B. Lespérance, R. Pichette, M. Plante, L. Provencher, Patricia Voyer, D. Goldgar, P. Bridge, J. Simard (2006)No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families.
Genetic testing, 10 2
P. Vasickova, E. Macháčková, M. Lukešová, J. Damborský, O. Horký, Hana Pavlu, Jitka Kuklova, V. Kosinová, M. Navratilova, L. Foretova (2007)High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic
BMC Medical Genetics, 8
C. Scriver (2001)Human Genetics: Lessons from Quebec Populations1
Annual Review of Genomics and Human Genetics, 2
S Hodgson, A. Coonar, P Hanson, S. Cottrell, P Scriven, T. Jones, P Hawley, M Wilkinson (1993)Two cases of 5q deletions in patients with familial adenomatous polyposis: possible link with Caroli's disease.
Journal of Medical Genetics, 30
Ruth Gershoni-Baruch, E. Dagan, G. Fried, R. Bar-Sade, R. Sverdlov-Shiri, G. Zelicksson, Eitan Friedman, Eitan Friedman (2000)Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer.
European journal of cancer, 36 8
J. Simard, P. Tonin, F. Durocher, K. Morgan, J. Rommens, S. Gingras, Chantal Samson, J. Leblanc, Carole Bélanger, F. Dion, Qingyun Liu, M. Skolnick, M. Skolnick, D. Goldgar, D. Shattuck-Eidens, F. Labrie, S. Narod (1994)Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families
Nature Genetics, 8
W. Foulkes, P. Ghadirian, M. Akbari, N. Hamel, S. Giroux, N. Sabbaghian, A. Darnel, R. Royer, A. Poll, Eve Fafard, A. Robidoux, G. Martin, T. Bismar, M. Tischkowitz, F. Rousseau, S. Narod (2007)Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women
Breast Cancer Research : BCR, 9
S. Ramus, P. Harrington, C. Pye, R. Dicioccio, M. Cox, K. Garlinghouse-Jones, I. Oakley-Girvan, I. Jacobs, R. Hardy, A. Whittemore, B. Ponder, M. Piver, P. Pharoah, S. Gayther (2007)Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer
Human Mutation, 28
P. Tonin, C. Maugard, C. Perret, A. Mes-Masson, D. Provencher (2007)A review of histopathological subtypes of ovarian cancer in BRCA-related French Canadian cancer families
Familial Cancer, 6
N. Loman, O. Johannsson, U. Kristoffersson, Hampus Olsson, Å. Borg (2001)Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.
Journal of the National Cancer Institute, 93 16
A. Antoniou, F. Durocher, Paula Smith, J. Simard, D. Easton (2005)BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families
Breast Cancer Research, 8
A. Woodward, T. Davis, A. Silva, Judy Kirk, Jennifer Leary (2005)Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families
Journal of Medical Genetics, 42
Paula Smith, L. McGuffog, D. Easton, G. Mann, G. Pupo, B. Newman, G. Chenevix-Trench, C. Szabo, M. Southey, H. Renard, F. Odefrey, H. Lynch, D. Stoppa-Lyonnet, F. Couch, J. Hopper, G. Giles, M. Mccredie, S. Buys, I. Andrulis, R. Senie, D. Goldgar, R. Oldenburg, K. Kroeze-Jansema, J. Kraan, H. Meijers-Heijboer, J. Klijn, C. Asperen, I. Leeuwen, H. Vasen, C. Cornelisse, P. Devilee, L. Baskcomb, S. Seal, R. Barfoot, J. Mangion, A. Hall, S. Edkins, E. Rapley, R. Wooster, J. Chang-Claude, D. Eccles, D. Evans, P. Futreal, K. Nathanson, B. Weber, N. Rahman, M. Stratton (2006)A genome wide linkage search for breast cancer susceptibility genes
S. Gutiérrez‐Enríquez, J. Balmaña, M. Baiget, O. Díez (2008)Detection of the CHEK2 1100delC mutation by MLPA BRCA1/2 analysis: a worthwhile strategy for its clinical applicability in 1100delC low-frequency populations?
Breast Cancer Research and Treatment, 107
S. Hodgson, Elizabeth Heap, June Cameron, D. Ellis, C. Mathew, R. Eeles, E. Solomon, C. Lewis (1999)Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
Journal of Medical Genetics, 36
A. Laberge, J. Michaud, A. Richter, E. Lemyre, M. Lambert, B. Brais, G. Mitchell (2005)Population history and its impact on medical genetics in Quebec
Clinical Genetics, 68
K. Oros, P. Ghadirian, C. Greenwood, C. Perret, Zhen Shen, Yosabeth Paredes, S. Arcand, A. Mes-Masson, S. Narod, W. Foulkes, D. Provencher, P. Tonin (2004)Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations
International Journal of Cancer, 112
Alain Gagnon, Evelyne Heyer (2001)Fragmentation of the Québec population genetic pool (Canada): evidence from the genetic contribution of founders per region in the 17th and 18th centuries.
American journal of physical anthropology, 114 1
R. Houlston, J. Peto (2004)The search for low-penetrance cancer susceptibility alleles
N. Puget, N. Puget, D. Torchard, O. Serova-Sinilnikova, O. Serova-Sinilnikova, H. Lynch, J. Feunteun, G. Lenoir, G. Lenoir, S. Mazoyer, S. Mazoyer (1997)A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.
Cancer research, 57 5
A. Antoniou, D. Easton (2006)Risk prediction models for familial breast cancer.
Future oncology, 2 2
M. Montagna, M. Palma, C. Menin, S. Agata, A. Nicolo, L. Chieco‐Bianchi, E. D'andrea (2003)Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families.
Human molecular genetics, 12 9
Few studies have reported on the comprehensive BRCA1/2 mutation analyses of hereditary breast cancer (HBC) families of French Canadian descent. Here we report the investigation of 82 families with at least 3 cases of breast cancer evaluated for mutations by DNA sequencing and/or multiplex ligation-dependent probe amplification (MLPA) assay. DNA sequencing identified pathogenic mutations in 37 (45.1%) families, of which 70.2% were one of three recurring mutations (BRCA1:R1443X, BRCA2:8765delAG, and BRCA2:E1953X) frequently reported in this founder population; and variants of uncertain clinical significance in 7 (8.5%) families of which two harbored BRCA2:E3002K. MLPA analysis of the 38 DNA sequence-negative families did not reveal any large rearrangements in BRCA1/2. A phenotypic characterization of the cancer families based on pathogenic mutation status revealed that there were significantly fewer very young age at diagnosis breast cancer cases (<36 years) in mutation-negative families (5.9%, 9 of 153) than in BRCA1 (22.8%, 13 of 57; P = 0.0003) or BRCA2 (22.9%, 27 of 118; P < 1× 10E5) mutation-positive families. There were significantly more mutation-positive families (29 of 36, 80.6%) with a very young age of onset of breast cancer case than those that did not (8 of 39, 20.5%) (P < 10E6). The comprehensive mutation analysis of BRCA1/2 suggests that genomic rearrangements are unlikely to account for sequence-negative HBC families and affirms that the presence of a very young age of diagnosis of breast cancer is strongly predictive of mutation carrier status of French Canadian HBC families.
Familial Cancer – Springer Journals
Published: Aug 8, 2010
Access the full text.
Sign up today, get DeepDyve free for 14 days.